Glucagon-like peptide receptor agonists (GLP-1RAs) like Novo Nordisk’s semaglutide (Ozempic, Wegovy) and Eli Lilly’s ...
A study conducted using electronic health record data from a collective of U.S. health care systems found that most adults ...
Small studies link Ozempic and similar drugs to rare but serious eye conditions. However, experts say there's no need to ...
A telehealth company partnered with a pharmacy that lacked a required license, raising doubts about the safety and efficacy ...
For years, conventional wisdom has been that weight loss is a matter of willpower. Those who are overweight or obese just need to try harder to eat less and exercise more. But while diet and ...
Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...
A recent study has found that the diabetes drug tirzepatide helps people with type 2 diabetes lower their blood sugar and ...
As demand remains high for GLP-1 drugs, primary care physicians are concerned about the risks of patients using third-party ...
In the glittering world of celebrity-endorsed weight loss transformations and viral before-and-after photos, a darker narrative is emerging from the shadows ...
Research links weight loss medications like Ozempic and Zepbound to certain serious eye conditions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback